Companies · Healthtech
ALEXANDRIA · CA, USA · Healthtech · refined from filed group “Other” · founded 2020 · https://www.scout.ml/
Diligence memoA one-page analyst read on Scout Inc. — recommendation, valuation, rhythm, risks.→Scout Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Scout Inc. is one of 2138 Healthtech companies tracked from ALEXANDRIA, CA, USA, on record since 2020. By capital raised it ranks in the long tail (ahead of 12% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
Dead simple CI/CD for ML teams
Digital health holds a lot of potential but is ignoring a growing problem: diagnostic testing. Without this data, providers and organizations will be limited in the services they can provide patients at home. Scout has developed a platform - Hub, test kits, and app - that delivers health testing at home with 10x lower development cost and 3x lower per-test price. Our patented tech also meets performance requirements for medical diagnoses and integrates with the current healthcare tech stack. Scout’s technology is poised to disrupt the outdated $33Bn diagnostic market by democratizing testing while dramatically improving the patient experience. Scout has received $16M in non-dilutive funding from the NIH and other organizations to fully de-risk our platform, and our pipeline includes a diverse test menu for primary care (e.g. respiratory and sexual health), wellness (e.g. gut health), and chronic conditions (e.g. certain cancers). We have already received FDA authorization for our platform in clinical settings and are planning to launch our flagship Scout Hub in 2024.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.
Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seed — a round under $1.0M). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 12% of sector peers (real $). Modeled value above 19% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #129 of 139.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Hey Healthcare, Inc. | Pre-Seed | $2.0M | $34.5M | 3.33× |
| Levin Eye Care LLC | Pre-Seed | $1.0M | $34.5M | 3.33× |
| Miracle Leaf Health Centers, Corp. | Pre-Seed | $1.0M | $34.5M | 3.33× |
| Merrimac Medical Investors, LLC | Pre-Seed | $1.0M | $34.5M | 3.33× |
| nView medical Inc. | Pre-Seed | $1.5M | $34.5M | 3.33× |
| PRINE Health Holdings, LLC | Pre-Seed | $1.0M | $34.5M | 3.33× |
| Medical Records Now, Inc. | Pre-Seed | $2.0M | $34.5M | 3.33× |
| Emf Medical Devices Inc. | Pre-Seed | $1.0M | $34.5M | 3.33× |
| Texas Health Surgery Center Southwest Fort Worth, LLC | Pre-Seed | $980K | $33.8M | 3.26× |
| Veritas Medical Solutions LLC | Pre-Seed | $1.0M | $31.4M | 3.04× |
| HealthTech Arkansas Investments LLC | Pre-Seed | $815K | $28.1M | 2.72× |
| Medical Ingenuities, LLC | Pre-Seed | $997K | $26.9M | 2.60× |
| Scout Inc. this company | Pre-Seed | $150K | $3.4M | 0.33× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Pre-Seed | $150K | 2021-04-21 | $833K | $3.4M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| ERIC INGRAM | — | 1 other | 2021-04 |
| SERGIO GALLUCCI | — | — | 2021-04 |
Scout Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| ADTC Health Corp. | Healthtech | Pre-Seed | $150K | $4.7M | same sector · same stage |
| Autism Diagnostic Technologies, Inc. | Healthtech | Pre-Seed | $150K | $1.0M | same sector · same stage |
| Biocellular Medical Investments LLC | Healthtech | Pre-Seed | $150K | $420K | same sector · same stage |
| Care Thread, Inc. | Healthtech | Pre-Seed | $150K | $1.9M | same sector · same stage |
| Evergreen Healthcare Technology, Inc | Healthtech | Pre-Seed | $150K | $5.2M | same sector · same stage |
| Journal My Health, Inc. | Healthtech | Pre-Seed | $150K | $2.3M | same sector · same stage |
| Spectrum Health Products, Inc. | Healthtech | Pre-Seed | $150K | $5.2M | same sector · same stage |
| Standard Wellness Maryland, LLC | Healthtech | Pre-Seed | $150K | $5.2M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Scout Bio, Inc. | Biotech / Pharma | Series B | $104.2M | 76% |
| Sepsis Scout Wearables and AI to predict and prevent sepsis outside the hospital | AI / ML | — | — | 76% |
| Develop Health Inc. | Healthtech | Series B | $87.3M | 76% |
| Scout Holdings, Inc. | Other Technology | Seed | $44.3M | 75% |
| Untether Labs Scheduling software for digital health clinics to do more with less. | Healthtech | — | — | 75% |
| InnaMed At-home blood testing: measure + analyze + enhance. | Biotech | — | — | 75% |
| Herb Scout, Inc. | Other Technology | Pre-Seed | $42.4M | 75% |
| Circle Medical Modern primary care via video and in-person | Healthtech | — | — | 75% |
See where Scout Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Scout Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.